1
|
Manoochehri J, Masoumi Dehshiri R, Faraji H, Mohammadi S, Dastsooz H, Moradi T, Rezaei E, Sadeghi K, Fardaei M. Family screening for a novel ATP7B gene mutation, c.2335T>G, in the South of Iran. Iran J Ped Hematol Oncol 2014; 4:26-31. [PMID: 24734161 PMCID: PMC3980019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/19/2013] [Accepted: 12/30/2013] [Indexed: 12/05/2022]
Abstract
BACKGROUND Wilson disease (WD) is a rare autosomal recessive disorder, which leads to copper metabolism, due to mutations in ATP7B gene. The gene responsible for WD consists of 21 exons that span a genomic region of about 80 kb and encodes a copper transporting P-type ATPase (ATP7B), a protein consisting of 1465 amino acids. Identifying mutation in ATP7B gene is important to find carrier individuals for proper counseling. A novel mutation in exon 8 of ATP7B gene, c.2335T>G (p.Trp779Gly), with severe neuropsychiatric condition in the South of Iran, was recently identified. The aim of this study was to screen 120 individuals from a large family using a simple amplification refractory mutation system PCR (ARMS-PCR) for carrier screening in the South of Iran. MATERIALS AND METHODS 120 individuals from family relatives of an index case in the Nasr Abad, south of Iran, were studied for screening of the c.2335T>G mutation. One patient with homozygous mutation and one homozygous normal individual were used as controls in this experiment. RESULTS Altogether, 16 out of 120 (13.3%) individuals within this region had heterozygous mutation. One individual with homozygote mutation was also identified. CONCLUSION Identification of carriers in families with affected individuals is of great importance for counseling before marriage. The results of this study can be used for further counseling programs in this population.
Collapse
Affiliation(s)
- J Manoochehri
- Department of Medical Genetics, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran,Comprehensive Medical Genetics Centre, Shiraz, Iran
| | - R Masoumi Dehshiri
- Health Policy Research Center, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran
| | - H Faraji
- Comprehensive Medical Genetics Centre, Shiraz, Iran
| | - S Mohammadi
- Comprehensive Medical Genetics Centre, Shiraz, Iran
| | - H Dastsooz
- Department of Medical Genetics, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran,Department of Molecular Medicine, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran,Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
| | - T Moradi
- Comprehensive Medical Genetics Centre, Shiraz, Iran
| | - E Rezaei
- Comprehensive Medical Genetics Centre, Shiraz, Iran
| | - Kh Sadeghi
- Comprehensive Medical Genetics Centre, Shiraz, Iran
| | - M Fardaei
- Department of Medical Genetics, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran,Comprehensive Medical Genetics Centre, Shiraz, Iran,Department of Molecular Medicine, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran
| |
Collapse
|